Goodwin Procter LLP advised Mirati Therapeutics, Inc. on the deal.Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced its collaboration and license agreement with Zai Lab Limited (NASDAQ: ZLAB;…
Mirati Therapeutics’ Collaboration and License agreement with Zai Lab Limited


























